isabelobrien, Author at European Medical Journal - Page 29 of 70

Whitehouse

US authorises waiver for life-saving humanitarian assistance

Marco Rubio has authorised an “Emergency Humanitarian Waiver” that ensures continued access to HIV treatment funded by the US.

Anna Sureda

Hema Now: Episode 9: A Conversation with the EBMT President

Anna Sureda, Head of the Clinical Hematology Department, Institut Català d’Oncologia – Hospital Duran i Reynals, Barcelona, Spain; President of the European Society for Blood and Marrow Transplantation (EBMT)

The world

US funding pause potential threat to global HIV efforts, warns WHO

The World Health Organization has responded to the US government’s freezing of HIV funding as part of a broader pause in foreign aid.

The word spotlight on a blue background

Spotlight: January 2025

Catch up on January’s top pharma news, from major industry deals and cutting-edge medical innovations to advancements in women’s health.

Charl van Zyl, Lundbeck Pharmaceuticals

Lundbeck’s Charl van Zyl on a new era in neurology

The team are joined by Charl van Zyl, President and CEO, Lundbeck Pharmaceuticals, to discuss advances in the treatment of neurological disorders.

GSK and Oxford unite to advance cancer vaccine research

The new collaboration between GSK and the Univeristy of Oxford aims to explore cancer prevention through vaccination.

male and female symbols

Physicians feel unequipped to address women's health gaps

According to new findings by the HBA and FemTechnology, there are significant systemic challenges and unmet needs in women’s healthcare

The 2025 pharma forecast

Curious to know could happen in the industry in 2025? Join us as we talk to three guests about their top predictions for the year ahead.

Takeda takes lead role in Crohn’s Disease biomarker study

Takeda is serving as the Industry Lead in the newly launched INTERCEPT project – a multinational collaboration to identify predictive biomarkers for Crohn’s Disease.

Portrait of Matthew Hickling

5 minutes with... Dr Matthew Hickling, Allergan Aesthetics

Dr Matthew Hickling explores the science behind beauty, his role in aesthetics and the opportunities shaping the future of the field.